Non-Viral TCR Gene Therapy (clinicaltrials.gov) - Mar 12, 2024 - P2 | N=0 | Withdrawn | Sponsor: National Cancer Institute (NCI) | N=210 ➔ 0 | Trial completion date: Dec 2029 ➔ Mar 2024 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Dec 2028 ➔ Mar 2024
Enrollment change • Gene therapy • IO biomarker • Metastases • Trial completion date • Trial primary completion date • Trial withdrawal • Breast Cancer • Colorectal Cancer • Gastrointestinal Cancer • Gastrointestinal Disorder • Gene Therapies • Genito-urinary Cancer • Glioblastoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Solid Tumor
|